4D Molecular Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
FDMT
CUSIP
35104E100
Type
Equity
Class
COM
Num filings
152
Total reported value, excl. options
$1.24 B
Manager Report Date Value ($000) Shares Option Type